Evolent Health, Inc. (EVH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q3 '21: 222.5M Q4 '21: 248.4M Q1 '22: 297.1M Q2 '22: 319.9M Q3 '22: 352.6M Q4 '22: 382.4M Q1 '23: 427.7M Q2 '23: 469.1M Q3 '23: 511M Q4 '23: 556.1M Q1 '24: 639.7M Q2 '24: 647.1M Q3 '24: 621.4M Q4 '24: 646.5M Q1 '25: 483.6M Q2 '25: 444.3M Q3 '25: 479.5M Q4 '25: 468.7M Q1 '26: 496.2M Q2 '26: 652.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q1 '22: 77.3M Q2 '22: 70.2M Q3 '22: 86M Q4 '22: 83.1M Q1 '23: 117.2M Q2 '23: 117.2M Q3 '23: 124.4M Q4 '23: 101.6M Q1 '24: 104.1M Q2 '24: 106.8M Q3 '24: 80.7M Q4 '24: 75.7M Q1 '25: 102.5M Q2 '25: 100.4M Q3 '25: 99.8M Q4 '25: 97.3M Q1 '26: 83.8M Q2 '26: 80.8M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '21: -6.6M Q4 '21: -12.2M Q1 '22: -2.8M Q2 '22: -4.6M Q3 '22: 13M Q4 '22: -1.9M Q1 '23: -10.4M Q2 '23: -21.6M Q3 '23: -17.9M Q4 '23: -21.4M Q1 '24: -13.4M Q2 '24: 7.8M Q3 '24: -16.3M Q4 '24: -18.6M Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: 886K Q4 '25: -408.2M Q1 '26: -10.6M Q2 '26: -9.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '21: -13M Q4 '21: -5.6M Q1 '22: -5.3M Q2 '22: -4.6M Q3 '22: 2.1M Q4 '22: -11.3M Q1 '23: -20M Q2 '23: -34.3M Q3 '23: -25.3M Q4 '23: -33.4M Q1 '24: -17.3M Q2 '24: 1.6M Q3 '24: -23.1M Q4 '24: -22.8M Q1 '25: -64.6M Q2 '25: -19.9M Q3 '25: -20.9M Q4 '25: -429.1M Q1 '26: -26.6M Q2 '26: -28.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 200M 400M 600M Q3 '21: 163.1M Q4 '21: 164.5M Q1 '22: 219.7M Q2 '22: 249.7M Q3 '22: 266.6M Q4 '22: 299.4M Q1 '23: 310.5M Q2 '23: 351.9M Q3 '23: 386.6M Q4 '23: 454.4M Q1 '24: 535.5M Q2 '24: 540.3M Q3 '24: 540.7M Q4 '24: 570.8M Q1 '25: 381.2M Q2 '25: 343.9M Q3 '25: 379.8M Q4 '25: 371.5M Q1 '26: 412.5M Q2 '26: 571.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-70M -35M 0 35M 70M 105M Q2 '21: -24.2M Q3 '21: 44.5M Q4 '21: 66.7M Q1 '22: -57.4M Q2 '22: 13.7M Q3 '22: -3.5M Q4 '22: 35.7M Q1 '23: -8M Q2 '23: 654K Q3 '23: 60.5M Q4 '23: 89.4M Q1 '24: 4.9M Q2 '24: 21.4M Q3 '24: 18.7M Q1 '25: 4.6M Q2 '25: -30.3M Q3 '25: 15.8M Q4 '25: 48.8M Q1 '26: -984K Q2 '26: -9.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-90M -60M -30M 0 30M 60M 90M Q2 '21: -29.8M Q3 '21: 38.3M Q4 '21: 59.4M Q1 '22: -66M Q2 '22: 4.4M Q3 '22: -13.3M Q4 '22: 25M Q1 '23: -17M Q2 '23: -6.2M Q3 '23: 53.7M Q4 '23: 83.3M Q1 '24: -438K Q2 '24: 14.3M Q3 '24: 12.4M Q1 '25: -4M Q2 '25: -39.1M Q3 '25: 6.8M Q4 '25: 41M Q1 '26: -7.4M Q2 '26: -16.2M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '20: 84.8M Q2 '20: 85.3M Q3 '20: 85.2M Q1 '21: 84.7M Q2 '21: 85.4M Q3 '21: 85.8M Q1 '22: 89.5M Q2 '22: 90.1M Q3 '22: 99.3M Q1 '23: 107.8M Q2 '23: 111.3M Q3 '23: 112.3M Q1 '24: 114.1M Q2 '24: 114.7M Q3 '24: 114.9M Q1 '25: 115.3M Q2 '25: 115.9M Q3 '25: 114.1M Q1 '26: 111.9M Q2 '26: 112.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '20: -6.15 Q4 '20: -3.82 Q1 '21: -3.01 Q2 '21: -0.74 Q3 '21: -0.45 Q4 '21: -0.45 Q1 '22: -0.39 Q2 '22: -0.33 Q3 '22: -0.16 Q4 '22: -0.20 Q1 '23: -0.38 Q2 '23: -0.70 Q3 '23: -1.02 Q4 '23: -1.27 Q1 '24: -1.25 Q2 '25: -1.61 Q3 '25: -1.58 Q4 '25: -5.15 Q1 '26: -4.76 Q2 '26: -4.57 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.